Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM
NCT ID: NCT05036265
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2011-09-01
2021-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver Metastasis
NCT02350166
Laparoscopic Colorectal Surgery For Cancer- Long Term Survival
NCT00555295
Comparison of Laparoscopic and Open Surgery for Colorectal Malignancy in Obese Patients
NCT06221878
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
NCT00002575
Predictive Factors of Conversion in Laparoscopic Colorectal Cancer Resection
NCT04589975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received laparoscopic liver resection for colorectal liver metastases
* Patients who received the laparoscopic liver resection between September 2011 and mid-March 2020
Exclusion Criteria
* Refusal to participate in the study
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital Groeninge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. M. D'hondt
Dr Mathieu D'Hondt, Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B396201939301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.